Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDoğan, Mustafa
dc.contributor.authorMutiu, Levent C.
dc.contributor.authorYılmaz, İbrahim
dc.contributor.authorBilir, Bülent
dc.contributor.authorSaraçoğlu Varol, Gamze
dc.contributor.authorYıldırım Güzelant, Aliye
dc.date.accessioned2022-05-11T14:07:40Z
dc.date.available2022-05-11T14:07:40Z
dc.date.issued2016
dc.identifier.issn1876-0341
dc.identifier.issn1876-035X
dc.identifier.urihttps://doi.org/10.1016/j.jiph.2015.06.002
dc.identifier.urihttps://hdl.handle.net/20.500.11776/5173
dc.description.abstractThe aim of the present study was to increase awareness regarding the rational use of medicines. The data were obtained via the Material Resources Management System Module of the Ministry of Health. For the appropriateness of treatments, the Global Initiative for Asthma, the Global Initiative for Chronic Obstructive Lung Disease, and the guidelines for the rational use of medicines were used. We also investigated whether any de-escalation method or physical exercise was performed. Statistical analyses were performed using descriptive statistics to determine the mean, standard deviation, and frequency. The results showed that healthcare providers ignored potential drug reactions or adverse interactions, and reflecting the lack of adherence to the current treatment guides, 35.8% irrational use of medicines was recorded. Thus, de-escalation methods should be used to decrease costs or narrow the antibiotic spectrum, antibiotic selection should consider the resistance patterns, culturing methods should be analyzed, and monotherapy should be preferred over combination treatments. (C) 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Londonen_US
dc.identifier.doi10.1016/j.jiph.2015.06.002
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAsthmaen_US
dc.subjectCOPDen_US
dc.subjectRational use of drugsen_US
dc.subjectPneumoniaen_US
dc.subjectCommunity-Acquired Pneumoniaen_US
dc.subjectPulmonary-Embolismen_US
dc.subjectCost-Effectivenessen_US
dc.subjectManagementen_US
dc.subjectTraumaen_US
dc.subjectAsthmaen_US
dc.subjectCopden_US
dc.subjectCareen_US
dc.titleAre treatment guides and rational drug use policies adequately exploited in combating respiratory system diseases?en_US
dc.typearticleen_US
dc.relation.ispartofJournal of Infection and Public Healthen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları Ana Bilim Dalıen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göğüs Cerrahisi Ana Bilim Dalıen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fizik Tedavi ve Rehabilitasyon Ana Bilim Dalıen_US
dc.authorid0000-0003-2003-6337
dc.authorid0000-0003-2112-4056
dc.authorid0000-0002-3535-5704
dc.identifier.volume9en_US
dc.identifier.issue1en_US
dc.identifier.startpage42en_US
dc.identifier.endpage51en_US
dc.institutionauthorDoğan, Mustafa
dc.institutionauthorMutiu, Levent C.
dc.institutionauthorBilir, Bülent
dc.institutionauthorSaraçoğlu Varol, Gamze
dc.institutionauthorYıldırım Güzelant, Aliye
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid57196589837
dc.authorscopusid8531050000
dc.authorscopusid35197435300
dc.authorscopusid56715752200
dc.authorscopusid26536840100
dc.authorscopusid57191926529
dc.authorwosidYILMAZ, Ibrahim/H-6199-2019
dc.authorwosidBilir, Bülent/AAK-5656-2021
dc.identifier.wosWOS:000368264800009en_US
dc.identifier.scopus2-s2.0-84953639677en_US
dc.identifier.pmid26166817en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster